Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bionnovation is a Brazilian medical device company that specializes in the development and manufacture of advanced biomaterials and dental implant systems. Founded in 1993 and headquartered in Bauru, the company provides a comprehensive portfolio of products for guided bone and tissue regeneration, including bovine-derived xenografts, synthetic bone substitutes, and titanium meshes. Their flagship product lines, such as Bonefill and Surgitime, are widely used in oral and maxillofacial surgeries to treat bone defects and support dental implant stability. Bionnovation maintains international quality standards, including ISO 13485 and CE certification, enabling the distribution of its products to global markets across Europe, Latin America, and the Middle East. The company focuses on providing cost-effective, high-quality surgical solutions for complex dental rehabilitations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bionnovation Biomedical.